Baidu
map

Circulation:过敏毒素受体C3aR参与调节血小板功能和动脉血栓形成原始出处:

2018-10-23 MedSci MedSci原创

血小板在血管系统中具有独特的功能,既是血栓形成的主要介质,对恢复组织完整性至关重要,又在血管炎症环境下发挥重要作用。补体系统是抵御微生物入侵的第一道防线,是炎症的重要介质。虽然补体和凝血系统之间的液相交叉很受重视,但其相互作用的病理生理意义尚不明确。研究人员采用流式细胞术分析了501位冠状动脉疾病患者血小板上激活的糖蛋白IIb/IIIa和过敏毒素受体C3aR共表达的情况;采用qPCR、免疫荧光、W

血小板在血管系统中具有独特的功能,既是血栓形成的主要介质,对恢复组织完整性至关重要,又在血管炎症环境下发挥重要作用。补体系统是抵御微生物入侵的第一道防线,是炎症的重要介质。虽然补体和凝血系统之间的液相交叉很受重视,但其相互作用的病理生理意义尚不明确。

研究人员采用流式细胞术分析了501位冠状动脉疾病患者血小板上激活的糖蛋白IIb/IIIa和过敏毒素受体C3aR共表达的情况;采用qPCR、免疫荧光、Western blotting或流式细胞术检测人或小鼠C3aR的表达水平;同时采用多种体外血小板功能试验、活体出血时间和活体镜检法检验血小板C3aR的重要性。通过心肌梗死和中风的疾病模型来观察C3aR的病理生理相关性。此外,研究人员还采用纳米级液相色谱与串联质谱联合鉴定血小板小GTPase Rap1b,来探究潜在的分子机制。

研究人员发现在冠状动脉疾病患者中,血小板补体C3aR的表达和激活的糖蛋白IIb/IIIa呈正相关,而且C3aR和糖蛋白IIb/IIIa在心肌梗死患者的血栓中共表达。研究人员还发现血小板上的C3a/C3aR轴可调节血栓形成的不同步骤,例如血小板黏附、扩张和Ca2+内流。通过给C3aR-/-或C3-/-小鼠注射C3a,研究人员发现补体激活片段C3a可调节尾巴受伤和血栓后的出血时间。值得注意的是,C3aR-/-小鼠不容易发生实验中风和心肌梗死。而且,用C3aR+/+血小板调整C3aR-/-小鼠和敲除血小板的实验表明研究过程中所观察到的对血栓形成、心肌梗死和中风的效应是由血小板C3aR引起的。机制上,即在受伤或者体内血栓形成后,C3aR介导的信号调节激活Rap1b,进而阻断出血。

总体上,本研究揭示了过敏毒素C3a在血小板功能和血栓形成方面的新功能,强调了心血管疾病中补体激活失衡的有害作用。


原始出处:

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1708995, encodeId=91b31e0899521, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Mon Jun 10 09:18:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780497, encodeId=f44f1e804975d, content=<a href='/topic/show?id=c88839081b' target=_blank style='color:#2F92EE;'>#C3aR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3908, encryptionId=c88839081b, topicName=C3aR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sat Sep 07 21:18:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082158, encodeId=1f6120821585b, content=<a href='/topic/show?id=c4d73e167d2' target=_blank style='color:#2F92EE;'>#原始出处#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37167, encryptionId=c4d73e167d2, topicName=原始出处)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Mon Nov 26 07:18:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536819, encodeId=c9c51536819da, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560177, encodeId=313b15601e740, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566186, encodeId=06bb156618603, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350316, encodeId=8aeb35031629, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 23 23:09:09 CST 2018, time=2018-10-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1708995, encodeId=91b31e0899521, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Mon Jun 10 09:18:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780497, encodeId=f44f1e804975d, content=<a href='/topic/show?id=c88839081b' target=_blank style='color:#2F92EE;'>#C3aR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3908, encryptionId=c88839081b, topicName=C3aR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sat Sep 07 21:18:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082158, encodeId=1f6120821585b, content=<a href='/topic/show?id=c4d73e167d2' target=_blank style='color:#2F92EE;'>#原始出处#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37167, encryptionId=c4d73e167d2, topicName=原始出处)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Mon Nov 26 07:18:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536819, encodeId=c9c51536819da, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560177, encodeId=313b15601e740, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566186, encodeId=06bb156618603, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350316, encodeId=8aeb35031629, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 23 23:09:09 CST 2018, time=2018-10-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1708995, encodeId=91b31e0899521, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Mon Jun 10 09:18:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780497, encodeId=f44f1e804975d, content=<a href='/topic/show?id=c88839081b' target=_blank style='color:#2F92EE;'>#C3aR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3908, encryptionId=c88839081b, topicName=C3aR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sat Sep 07 21:18:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082158, encodeId=1f6120821585b, content=<a href='/topic/show?id=c4d73e167d2' target=_blank style='color:#2F92EE;'>#原始出处#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37167, encryptionId=c4d73e167d2, topicName=原始出处)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Mon Nov 26 07:18:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536819, encodeId=c9c51536819da, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560177, encodeId=313b15601e740, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566186, encodeId=06bb156618603, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350316, encodeId=8aeb35031629, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 23 23:09:09 CST 2018, time=2018-10-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1708995, encodeId=91b31e0899521, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Mon Jun 10 09:18:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780497, encodeId=f44f1e804975d, content=<a href='/topic/show?id=c88839081b' target=_blank style='color:#2F92EE;'>#C3aR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3908, encryptionId=c88839081b, topicName=C3aR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sat Sep 07 21:18:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082158, encodeId=1f6120821585b, content=<a href='/topic/show?id=c4d73e167d2' target=_blank style='color:#2F92EE;'>#原始出处#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37167, encryptionId=c4d73e167d2, topicName=原始出处)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Mon Nov 26 07:18:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536819, encodeId=c9c51536819da, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560177, encodeId=313b15601e740, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566186, encodeId=06bb156618603, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350316, encodeId=8aeb35031629, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 23 23:09:09 CST 2018, time=2018-10-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1708995, encodeId=91b31e0899521, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Mon Jun 10 09:18:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780497, encodeId=f44f1e804975d, content=<a href='/topic/show?id=c88839081b' target=_blank style='color:#2F92EE;'>#C3aR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3908, encryptionId=c88839081b, topicName=C3aR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sat Sep 07 21:18:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082158, encodeId=1f6120821585b, content=<a href='/topic/show?id=c4d73e167d2' target=_blank style='color:#2F92EE;'>#原始出处#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37167, encryptionId=c4d73e167d2, topicName=原始出处)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Mon Nov 26 07:18:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536819, encodeId=c9c51536819da, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560177, encodeId=313b15601e740, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566186, encodeId=06bb156618603, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350316, encodeId=8aeb35031629, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 23 23:09:09 CST 2018, time=2018-10-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1708995, encodeId=91b31e0899521, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Mon Jun 10 09:18:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780497, encodeId=f44f1e804975d, content=<a href='/topic/show?id=c88839081b' target=_blank style='color:#2F92EE;'>#C3aR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3908, encryptionId=c88839081b, topicName=C3aR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sat Sep 07 21:18:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082158, encodeId=1f6120821585b, content=<a href='/topic/show?id=c4d73e167d2' target=_blank style='color:#2F92EE;'>#原始出处#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37167, encryptionId=c4d73e167d2, topicName=原始出处)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Mon Nov 26 07:18:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536819, encodeId=c9c51536819da, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560177, encodeId=313b15601e740, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566186, encodeId=06bb156618603, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350316, encodeId=8aeb35031629, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 23 23:09:09 CST 2018, time=2018-10-23, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1708995, encodeId=91b31e0899521, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Mon Jun 10 09:18:00 CST 2019, time=2019-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780497, encodeId=f44f1e804975d, content=<a href='/topic/show?id=c88839081b' target=_blank style='color:#2F92EE;'>#C3aR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3908, encryptionId=c88839081b, topicName=C3aR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Sat Sep 07 21:18:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082158, encodeId=1f6120821585b, content=<a href='/topic/show?id=c4d73e167d2' target=_blank style='color:#2F92EE;'>#原始出处#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37167, encryptionId=c4d73e167d2, topicName=原始出处)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Mon Nov 26 07:18:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536819, encodeId=c9c51536819da, content=<a href='/topic/show?id=fcbd3332949' target=_blank style='color:#2F92EE;'>#动脉血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33329, encryptionId=fcbd3332949, topicName=动脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=715e12724163, createdName=yangcx0919, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560177, encodeId=313b15601e740, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566186, encodeId=06bb156618603, content=<a href='/topic/show?id=94c7333316b' target=_blank style='color:#2F92EE;'>#动脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33331, encryptionId=94c7333316b, topicName=动脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ec15082272, createdName=tonychen26, createdTime=Thu Oct 25 13:18:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350316, encodeId=8aeb35031629, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 23 23:09:09 CST 2018, time=2018-10-23, status=1, ipAttribution=)]
    2018-10-23 天地飞扬

    了解一下,谢谢分享!

    0

Baidu
map
Baidu
map
Baidu
map